143 related articles for article (PubMed ID: 37016545)
1. The association between nonalcoholic fatty liver disease and corrected QT interval prolongation among generally healthy Iranian population: Fasa Cohort Study (FACS).
Naderi A; Farjam M; Mojarrad Sani M; Abdollahi A; Alkamel A; Keshavarzian O; Tabrizi R
Clin Cardiol; 2023 Jun; 46(6):615-621. PubMed ID: 37016545
[TBL] [Abstract][Full Text] [Related]
2. Nonalcoholic Fatty Liver Disease as a Risk Factor for Prolonged Corrected QT Interval in Apparently Healthy Korean Women.
Chung TH; Shim JY; Lee YJ
J Gastrointestin Liver Dis; 2020 Mar; 29(1):59-64. PubMed ID: 32176760
[TBL] [Abstract][Full Text] [Related]
3. Nonalcoholic Fatty Liver Disease Is Associated With QT Prolongation in the General Population.
Hung CS; Tseng PH; Tu CH; Chen CC; Liao WC; Lee YC; Chiu HM; Lin HJ; Ho YL; Yang WS; Wu MS; Chen MF
J Am Heart Assoc; 2015 Jul; 4(7):. PubMed ID: 26199227
[TBL] [Abstract][Full Text] [Related]
4. Association of nonalcoholic fatty liver disease with QTc interval in patients with type 2 diabetes.
Targher G; Valbusa F; Bonapace S; Bertolini L; Zenari L; Pichiri I; Mantovani A; Zoppini G; Bonora E; Barbieri E; Byrne CD
Nutr Metab Cardiovasc Dis; 2014 Jun; 24(6):663-9. PubMed ID: 24594085
[TBL] [Abstract][Full Text] [Related]
5. Nonalcoholic Fatty Liver Disease Is Related to Abnormal Corrected QT Interval and Left Ventricular Hypertrophy in Chinese Male Steelworkers.
Hung WC; Yu TH; Wu CC; Lee TL; Tang WH; Chen CC; Lu IC; Chung FM; Lee YJ; Hsu CC
Int J Environ Res Public Health; 2022 Nov; 19(21):. PubMed ID: 36361436
[TBL] [Abstract][Full Text] [Related]
6. The best QT correction formula in a non-hospitalized population: the Fasa PERSIAN cohort study.
Yazdanpanah MH; Naghizadeh MM; Sayyadipoor S; Farjam M
BMC Cardiovasc Disord; 2022 Feb; 22(1):52. PubMed ID: 35172723
[TBL] [Abstract][Full Text] [Related]
7. Factors associated with prolonged QTc interval in Iranian population: MASHAD cohort study.
Sahranavard T; Soflaei SS; Alimi R; Pourali G; Nasrabadi M; Yadollahi A; Sharifi S; Alimi H; Shahri B; Ghalibaf AM; Metanat S; Ferns GA; Moohebati M; Ghayour-Mobarhan M
J Electrocardiol; 2024; 84():112-122. PubMed ID: 38631278
[TBL] [Abstract][Full Text] [Related]
8. Gender impacts on the correlations between nonalcoholic fatty liver disease and hypertension in a Chinese population aged 45-60 y.
Li XD; Qiu BH; Su FC; Sun SX
Clin Exp Hypertens; 2016; 38(7):639-643. PubMed ID: 27680771
[TBL] [Abstract][Full Text] [Related]
9. Different body parts' fat mass and corrected QT interval on the electrocardiogram: The Fasa PERSIAN Cohort Study.
Yazdanpanah MH; Bahramali E; Naghizadeh MM; Farjam M; Mobasheri M; Dadvand S
BMC Cardiovasc Disord; 2021 Jun; 21(1):277. PubMed ID: 34090333
[TBL] [Abstract][Full Text] [Related]
10. Association of Nonalcoholic Fatty Liver Disease With Lower Brain Volume in Healthy Middle-aged Adults in the Framingham Study.
Weinstein G; Zelber-Sagi S; Preis SR; Beiser AS; DeCarli C; Speliotes EK; Satizabal CL; Vasan RS; Seshadri S
JAMA Neurol; 2018 Jan; 75(1):97-104. PubMed ID: 29159396
[TBL] [Abstract][Full Text] [Related]
11. Sex difference in the relationship between insulin resistance and corrected QT interval in non-diabetic subjects.
Shin HS; Lee WY; Kim SW; Jung CH; Rhee EJ; Kim BJ; Sung KC; Kim BS; Kang JH; Lee MH; Park JR
Circ J; 2005 Apr; 69(4):409-13. PubMed ID: 15791034
[TBL] [Abstract][Full Text] [Related]
12. Remnant cholesterol, stronger than triglycerides, is associated with incident non-alcoholic fatty liver disease.
Cheng Y; Zhang Q; Li H; Zhou G; Shi P; Zhang X; Guan L; Yan F; Xu C
Front Endocrinol (Lausanne); 2023; 14():1098078. PubMed ID: 37214248
[TBL] [Abstract][Full Text] [Related]
13. The association between dietary inflammation scores and non-alcoholic fatty liver diseases in Iranian adults.
Farhadnejad H; Tehrani AN; Jahromi MK; Teymoori F; Mokhtari E; Salehi-Sahlabadi A; Mirmiran P
BMC Gastroenterol; 2022 May; 22(1):267. PubMed ID: 35644622
[TBL] [Abstract][Full Text] [Related]
14. Nonalcoholic Fatty Liver Disease Is Associated With Ventricular Arrhythmias in Patients With Type 2 Diabetes Referred for Clinically Indicated 24-Hour Holter Monitoring.
Mantovani A; Rigamonti A; Bonapace S; Bolzan B; Pernigo M; Morani G; Franceschini L; Bergamini C; Bertolini L; Valbusa F; Rigolon R; Pichiri I; Zoppini G; Bonora E; Violi F; Targher G
Diabetes Care; 2016 Aug; 39(8):1416-23. PubMed ID: 27222503
[TBL] [Abstract][Full Text] [Related]
15. Non-high-density lipoprotein cholesterol independently predicts new onset of non-alcoholic fatty liver disease.
Zelber-Sagi S; Salomone F; Yeshua H; Lotan R; Webb M; Halpern Z; Santo E; Oren R; Shibolet O
Liver Int; 2014 Jul; 34(6):e128-35. PubMed ID: 24118857
[TBL] [Abstract][Full Text] [Related]
16. Non-alcoholic fatty liver disease (NAFLD) and 10-year risk of cardiovascular diseases.
Motamed N; Rabiee B; Poustchi H; Dehestani B; Hemasi GR; Khonsari MR; Maadi M; Saeedian FS; Zamani F
Clin Res Hepatol Gastroenterol; 2017 Feb; 41(1):31-38. PubMed ID: 27597641
[TBL] [Abstract][Full Text] [Related]
17. Prolonged QTc interval and risk of sudden cardiac death in a population of older adults.
Straus SM; Kors JA; De Bruin ML; van der Hooft CS; Hofman A; Heeringa J; Deckers JW; Kingma JH; Sturkenboom MC; Stricker BH; Witteman JC
J Am Coll Cardiol; 2006 Jan; 47(2):362-7. PubMed ID: 16412861
[TBL] [Abstract][Full Text] [Related]
18. Prolongation of the QTc interval in HIV-infected individuals compared to the general population.
Reinsch N; Arendt M; Geisel MH; Schulze C; Holzendorf V; Warnke A; Neumann T; Brockmeyer NH; Schadendorf D; Eisele L; Erbel R; Moebus S; Jöckel KH; Esser S;
Infection; 2017 Oct; 45(5):659-667. PubMed ID: 28776165
[TBL] [Abstract][Full Text] [Related]
19. Epicardial adipose tissue predicted prolonged QTc interval in patients with arterial hypertension.
Yılmaz AS; Çinier G; Çırakoğlu ÖF; Çetin M
Clin Exp Hypertens; 2021 Apr; 43(3):230-236. PubMed ID: 33183070
[No Abstract] [Full Text] [Related]
20. Increased levels of low-density lipoprotein cholesterol within the normal range as a risk factor for nonalcoholic fatty liver disease.
Sun DQ; Liu WY; Wu SJ; Zhu GQ; Braddock M; Zhang DC; Shi KQ; Song D; Zheng MH
Oncotarget; 2016 Feb; 7(5):5728-37. PubMed ID: 26735337
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
